Under Rs 1 Pharma Stock Revises Bonus Shares Timeline, New Record Date 1st Aug For 1:10 Issue; Buy Today?

Indian pharmaceutical company Murae Organisor Limited was originally Earum Pharmaceuticals Private Limited. Since the Board extended the bonus share record date from July 29 to August 1, Murae Organisor, one of the penny stocks, will draw the attention of market observers. Although the stock, which is currently selling at Rs 0.89 per share with a market capitalization of Rs 165.45 Cr on the BSE, may present a trading opportunity for bonus shares, traders should also examine chart patterns before acting.

Murae Organisor Bonus Shares Record Date

"Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we would like to inform you that the Company has Revised and fixed Friday, 01st August, 2025 as the Record Date, for the purpose of ascertaining the eligibility of the shareholders entitled for Bonus issue of Equity shares, in accordance with the approval of shareholders obtained through postal ballot on Wednesday, 23rd July,2025. Issue of 1 (One) Bonus Shares for every 10 (Ten) Equity Shares held by the Equity Shareholders of the Company," said Murae Organisor in a stock exchange filing.

Murae Organisor Bonus Shares Announcement Date

The Board of Murae Organisor announced on June 18, 2025, that the eligible equity shareholders of the firm as of the record date would receive 1:10 bonus shares, or one new fully paid-up equity share of Rs 1/-each for every ten existing fully paid-up equity shares of Rs 1/-each. The pre-bonus issue paid-up share capital as of date was 1,85,89,64,310 equity shares of Rs. 1/- each aggregating Rs. 1,85,89,64,310, whereas the post-bonus issue paid-up share capital will be 2,04,48,60,741 equity shares of Rs. 1/- each aggregating Rs. 2,04,48,60,741.

Murae Organisor Target Price

"Murae Organisor stock price is bearish on the daily charts with strong resistance at 0.93. A daily close below support of 0.85 could lead to a target of 0.70 in the near term," commented A R Ramachandran, independent research analyst.

Disclaimer

The recommendations made above are by market analysts and are not advised by either the author, nor GoodReturns. The author, nor the brokerage firm nor GoodReturns would be liable for any losses caused as a result of decisions based on this write-up. Goodreturns.in advises users to consult with certified experts before making any investment decision.